اختلال کمبود توجه بیش فعالی در بیماران مبتلا به بیماری قلبی مادرزادی

نوع مقاله : مقاله پژوهشی

نویسندگان

1 Associate professor of pediatric and congenital cardiology, Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Assistant professor of psychiatry, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Assistant professor of child and adolescent psychiatry, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

10.22038/jfmh.2023.21666

چکیده

مقدمه: ناتوانی‌های عصبی رشدی، به‌ویژه اختلالات عملکرد اجرایی، در حال حاضر شایع‌ترین عوارض طولانی‌مدت در جمعیت مبتلا به بیماری‌های مادرزادی قلب (CHD) هستند. این مطالعه با هدف بررسی فراوانی اختلال نقص توجه و بیش فعالی (ADHD) در کودکان مبتلا به بیماری مادرزادی قلبی انجام شد.
روش‌ کار: این مطالعه یک مطالعه همگروهی گذشته‌نگر بود که طی سال‌های 1381 تا 1397 بر روی بیماران مبتلا به CHD مراجعه‌کننده به کلینیک قلب کودکان بیمارستان امام رضا(ع) مشهد انجام شد. با استفاده از روش سرشماری، کلیه پرونده­های با تشخیص ADHD در مطالعه گنجانده شدند. تشخیص CHD به صورت بالینی و با استفاده از دستگاه اکوکاردیوگرافی توسط متخصص قلب کودکان با تجربه انجام شد. اطلاعات دموگرافیک، بالینی و پاراکلینیکی بیماران و نوع مداخله قلبی، جمع­آوری و مورد تحلیل قرار گرفت. داده­ها با نرم­افزار SPSS نسخه 16.5، آمار توصیفی و آزمون مجذور خی، تحلیل شدند.
یافته‌ها: در این مطالعه 136 بیمار وارد مطالعه شدند. میانگین سنی شرکت­کنندگان در زمان تشخیص 84/45±12/59 ماه بود. الکتروانسفالوگرام غیرطبیعی (EEG) در سه مورد (2.2%) گزارش شد. بین نارس بودن و تاخیر رشد همبستگی معنی­داری وجود داشت (01/0P= ). میانگین سنی در بیماران مبتلا به اختلالات قلبی جزئی نسبت به افراد دارای اختلالات قلبی عمده، تفاوت معنی­داری داشت  (05/0> (P . شیوع ADHD در جمعیت CHD بالا بود (31.6%).
نتیجه‌گیری: این مطالعه نشان داد که کودکانی که با بیماری‌های مادرزادی قلبی متولد می‌شوند در معرض افزایش خطر ابتلا به اختلال نقص توجه و بیش فعالی هستند.

کلیدواژه‌ها


  1. Zhao L, Chen L, Yang T, Wang T, Zhang S, Chen L, et al. Birth prevalence of congenital heart disease in China, 1980–2019: A systematic review and meta-analysis of 617 studies. Eur J Epidemiol 2020; 35(7): 631-42.
  2. Griffin KJ, Elkin TD, Smith CJ. Academic outcomes in children with congenital heart disease. Clin Pediatr 2003; 42(5): 401-9.
  3. Wray J, Sensky T. Congenital heart disease and cardiac surgery in childhood: Effects on cognitive function and academic ability. Heart 2001; 85(6): 687-91.
  4. Rosenthal A, Castaneda AR. Growth and development after cardiovascular surgery in infants and children. Prog Cardiovasc Dis 1975; 18(1): 27-37.
  5. Bass JL, Corwin M, Gozal D, Moore C, Nishida H, Parker S, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: A review of the evidence. Pediatrics 2004; 114(3): 805-16.
  6. Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management: A scientific statement from the American Heart Association. Circulation 2012; 126(9): 1143-72.
  7. Diamond A. Executive functions. Ann Rev Psychol 2013; 64: 135-68.
  8. Blair C, Razza RP. Relating effortful control, executive function, and false belief understanding to emerging math and literacy ability in kindergarten. Child Dev 2007; 78(2): 647-63.
  9. Diamond A, Barnett WS, Thomas J, Munro S. Preschool program improves cognitive control. Science (New York, NY) 2007; 318(5855): 1387.
  10. Bellinger DC, Wypij D, Rivkin MJ, DeMaso DR, Robertson Jr RL, Dunbar-Masterson C, et al. Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: Neuropsychological assessment and structural brain imaging. Circulation 2011; 124(12): 1361-9.
  11. Bellinger DC, Watson CG, Rivkin MJ, Robertson RL, Roberts AE, Stopp C, et al. Neuropsychological status and structural brain imaging in adolescents with single ventricle who underwent the Fontan procedure. J Am Heart Assoc 2015; 4(12): e002302.
  12. Gaynor JW, Ittenbach RF, Gerdes M, Bernbaum J, Clancy RR, McDonald-McGinn DM, et al. Neurodevelopmental outcomes in preschool survivors of the Fontan procedure. J Thorac Cardiovasc Surg 2014; 147(4): 1276-83.
  13. Cassidy AR, White MT, DeMaso DR, Newburger JW, Bellinger DC. Executive function in children and adolescents with critical cyanotic congenital heart disease. J Int Neuropsychol Soc 2015; 21(1): 34-49.
  14. Calderon J, Jambaqué I, Bonnet D, Angeard N. Executive functions development in 5-to 7-year-old children with transposition of the great arteries: A longitudinal study. Dev Neuropsychol 2014; 39(5): 365-84.
  15. Yamada DC, Porter AA, Conway JL, LeBlanc JC, Shea SE, Hancock-Friesen CL, et al. Early repair of congenital heart disease associated with increased rate of attention deficit hyperactivity disorder symptoms. Can J Cardiol 2013; 29(12): 1623-8.
  16. Goldberg CS, Mussatto K, Licht D, Wernovsky G. Neurodevelopment and quality of life for children with hypoplastic left heart syndrome: current knowns and unknowns. Cardiol Young 2011; 21 Suppl 2(02): 88-92.
  17. Neal AE, Stopp C, Wypij D, Bellinger DC, Dunbar-Masterson C, DeMaso DR, et al. Predictors of health-related quality of life in adolescents with tetralogy of Fallot. J Pediatr 2015; 166(1): 132-8.
  18. DeMaso DR, Labella M, Taylor GA, Forbes PW, Stopp C, Bellinger DC, et al. Psychiatric disorders and function in adolescents with d-transposition of the great arteries. J Pediatr 2014; 165(4): 760-6.
  19. Luyckx K, Rassart J, Goossens E, Apers S, Oris L, Moons P. Development and persistence of depressive symptoms in adolescents with CHD. Cardiol Young 2016; 26(6): 1115-22.
  20. Matte B, Anselmi L, Salum GA, Kieling C, Gonçalves H, Menezes A, et al. ADHD in DSM-5: A field trial in a large, representative sample of 18- to 19-year-old adults. Psychol Med 2015; 45(2): 361-73.
  21. Hansen E, Poole TA, Nguyen V, Lerner M, Wigal T, Shannon K, et al. Prevalence of ADHD symptoms in patients with congenital heart disease. Pediatr Int 2012; 54(6): 838-43.
  22. Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol 2009; 137(2): 158-64.
  23. Razzaghi H, Oster M, Reefhuis J. Long-term outcomes in children with congenital heart disease: National Health Interview Survey. J Pediatr 2015; 166(1): 119-24.
  24. Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 2008; 121(4): e759-e67.
  25. Rosenthal GL. Patterns of prenatal growth among infants with cardiovascular malformations: Possible fetal hemodynamic effects. Am J Epidemiol 1996; 143(5): 505-13.
  26. Donofrio M, Bremer Y, Schieken R, Gennings C, Morton L, Eidem BW, et al. Autoregulation of cerebral blood flow in fetuses with congenital heart disease: the brain sparing effect. Pediatr Cardiol 2003; 24(5): 436-43.
  27. Rollins CK, Watson CG, Asaro LA, Wypij D, Vajapeyam S, Bellinger DC, et al. White matter microstructure and cognition in adolescents with congenital heart disease. J Pediatr 2014; 165(5): 936-44.
  28. Khalil A, Bennet S, Thilaganathan B, Paladini D, Griffiths P, Carvalho JS. Prevalence of prenatal brain abnormalities in fetuses with congenital heart disease: A systematic review. Ultrasound Obstet Gynecol 2016; 48(3): 296-307.
  29. Donofrio MT, Massaro AN. Impact of congenital heart disease on brain development and neurodevelopmental outcome. Int J Pediatr 2010; 2010: 359390.
  30. Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006; 27(4): 408-13.
  31. Sharma R, Bolger AP, Li W, Davlouros PA, Volk H-D, Poole-Wilson PA, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 2003; 92(2): 188-93.
  32. Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ, Myint A-M. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism-effects of medication.
    Behav Brain Funct 2010; 6(1): 1-14.
  33. Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation 2011; 8: 52.
  34. Tsao P-C, Lee Y-S, Jeng M-J, Hsu J-W, Huang K-L, Tsai S-J, et al. Additive effect of congenital heart disease and early developmental disorders on attention-deficit/hyperactivity disorder and autism spectrum disorder: A nationwide population-based longitudinal study. Eur Child Adolesc Psychiatry 2017; 26(11): 1351-9.
  35. Flanagan JE, Landa R, Bhat A, Bauman M. Head lag in infants at risk for autism: A preliminary study. Am J Occup Ther 2012; 66(5): 577-85.
  36. Gonzalez VJ, Kimbro RT, Cutitta KE, Shabosky JC, Bilal MF, Penny DJ, et al. Mental health disorders in children with congenital heart disease. Pediatrics2021; 147(2): e20201693.
  37. Mari MA, Cascudo MM, Alchieri JC. Congenital heart disease and impacts on child development. Braz J Cardiovasc Surg 2016; 31(1): 31-7.
  38. Lata K, Mishra D, Mehta V, Juneja M. Neurodevelopmental status of children aged 6–30 months with congenital heart disease. Indian Pediatr 2015; 52(11): 957-60.
  39. Almeida LFG, Araujo Júnior E, Crott GC, Okido MM, Berezowski AT, Duarte G, et al. [Epidemiological risk factors and perinatal outcomes of congenital anomalies]. Rev Bras Ginecol Obstet 2016; 38(7): 348-55. (Portuguese)
  40. Pringsheim T, Sandor P, Lang A, Shah P, O'Connor P. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2009; 30(2): 115-21.
  41. Decker MJ, Rye DB. Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning. Sleep Breath 2002; 6(4): 205-10.